Evaxion Biotech A/S (EVAX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Evaxion Biotech A/S (EVAX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

EVAX Cash Flow Statement

Evaxion Biotech A/S (EVAX) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	0	0	0	0	0	0	0	0	0	0	-2.01M	-4.39M	0	0	-5.83M	-6.57M	-5.19M	-8.19M	-4.12M	-6.29M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-2749.32%	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-	-	-	-	-	-	100%	100%	-	-	65.58%	33.15%	100%	100%	-41.7%	-4.32%	30.69%	-102.87%	6.33%	-127.67%
Net Income	-3.73M	-3.63M	-5.91M	4.62M	-4.83M	-1.58M	-3.6M	-1.94M	-6.2M	1.19M	-4.52M	-5.68M	-5.68M	-6.27M	-6.87M	-5.74M	-4.77M	-5.79M	-8.37M	-5.25M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	115K	200K	0	0	571K	0	0	0	0	0
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0	-21K	100K	0	0	-58K	300K	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	3.73M	3.63M	5.91M	-4.62M	4.83M	1.58M	3.6M	1.94M	6.2M	-1.19M	1.52M	281K	5.68M	6.27M	63K	-326K	-849K	-226K	2.41M	-139K
Working Capital Changes	0	0	0	0	0	0	0	0	0	0	904K	707K	0	0	465K	-801K	427K	-2.17M	1.84M	-906K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	707K	800K	0	0	-1.49M	1.1M	-1.1K	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	0	0	0	0	0	0	0	0	0	0	1K	-65K	0	0	56K	-88K	-77K	-159K	-177K	-331K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	1K	-65K	0	0	61K	-89K	-83K	-181K	-176K	-332K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	1.37%	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-5K	1K	6K	22K	-1K	1K
Cash from Financing	0	0	0	0	0	0	0	0	0	0	5.26M	96K	0	0	546K	-131K	-300K	7.74M	24.65M	-65K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	-118K	0	0	0	-189K	0	-107K	7.74M	-144K	-67K
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28K	0	25.95M	1K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0	5.38M	96K	0	0	735K	-131K	-221K	0	-1.16M	1K
Net Change in Cash	0	0	12.66M	0	0	0	1.38M	0	0	6.15M	2.98M	-4.51M	-3.12M	-2.94M	-4.67M	-7.4M	-6.16M	-757K	20.22M	-6.86M
Free Cash Flow	0	0	0	0	0	0	0	0	0	0	-2.01M	-4.46M	0	0	-5.77M	-6.66M	-5.27M	-8.37M	-4.29M	-6.63M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-2747.95%	-	-	-	-	-	-	-	-	-
FCF Growth %	-	-	-	-	-	-	100%	100%	-	-	65.23%	33.07%	100%	100%	-34.47%	-0.44%	34.07%	-91.16%	8.19%	-139.5%
FCF per Share	-	-	-	-	-	-	-	-	-	-	-2.94	-6.44	-	-	-9.56	-11.17	-8.85	-14.45	-7.92	-13.81
FCF Conversion (FCF/Net Income)	-	-	-	-	-	-	-	-	-	-	0.44x	0.77x	-	-	0.85x	1.14x	1.09x	1.41x	0.49x	1.20x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16K	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0